Current Concepts in Movement Disorder Management
Editor(s): Niranjan, A. (Pittsburgh, PA)Lunsford, L.D. (Pittsburgh, PA)
Richardson, R.M. (Pittsburgh, PA)
Clinical Presentation and Prognosis of Common Movement DisordersHan J. · Jain S.Department of Neurology, Movement Disorders Division, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: January 12, 2018
Cover Date: 2018
Number of Print Pages: 16
Number of Figures: 1
Number of Tables: 2
ISBN: 978-3-318-06201-4 (Print)
eISBN: 978-3-318-06202-1 (Online)
Abstract
Great progress has been made in expanding our understanding of the natural history of movement disorders, leading to impressive advancements in their medical and surgical management. Movement disorders are a diverse group of diseases, varying widely in clinical characteristics and evolution. Some are monosymptomatic while others have associated motor and nonmotor features. Some are static while others follow a progressive course. This chapter will review common primary and secondary movement disorders: Parkinson disease and other forms of Parkinsonism, essential tremor and its differential diagnoses, dystonia and tic disorders. Herein, we will provide an overview of the clinical presentation and prognosis of the primary and secondary movement disorders most relevant to discussions of surgical candidacy.
© 2018 S. Karger AG, Basel
Related Articles:
References
-
Ostrem JL, Galifianakis NB: Overview of common movement disorders. Continuum (Minneap Minn) 2010;16:13-48.
-
Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
-
Poewe W: The natural history of Parkinson's disease. J Neurol 2006;253(suppl 7):VII2-VII6.
-
Goetz CG, Tanner CM, Shannon KM: Progression of Parkinson's disease without levodopa. Neurology 1987;37:695-698.
-
Macleod AD, Taylor KS, Counsell CE: Mortality in Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2014;29:1615-1622.
-
Aarsland D, Zaccai J, Brayne C: A Systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005;20:1255-1263.
-
Hely MA, Morris JG, Reid WG, Trafficante R: Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-199.
-
Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG: The sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.
-
Wenning GK, Litvan I, Tolosa E: Milestones in atypical and secondary parkinsonisms. Mov Disord 2011;26:1083-1095.
-
Tolosa E, Coelho M, Gallardo M: DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord 2003;18(suppl 7):S28-S33.
-
Andren K, Wikkelso C, Tisell M, Hellstrom P: Natural course of idiopathic normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2014;85:806-810.
-
Louis ED, Ferreira JJ: How common is the most common adult movement disorder? update on the worldwide prevalence of essential tremor. Mov Disord 2010;25:534-541.
-
Louis ED, Agnew A, Gillman A, Gerbin M, Viner AS: Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor cases. J Neurol Neurosurg Psychiatry 2011;82:761-765.
-
Louis ED, Benito-Leon J, Ottman R, Bermejo-Pareja F: A population-based study of mortality in essential tremor. Neurology 2007;69:1982-1989.
-
Benito-Leon J, Louis ED, Bermejo-Pareja F: Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry 2009;80:423-425.
-
Bermejo-Pareja F, Louis ED, Benito-Leon J: Risk of incident dementia in essential tremor: a population-based study. Mov Disord 2007;22:1573-1580.
-
Louis ED, Rios E, Henchcliffe C: How are we doing with the treatment of essential tremor (ET)?: persistence of patients with ET on medication: data from 528 patients in three settings. Eur J Neurol 2010;17:882-884.
-
Deuschl G, Raethjen J, Hellriegel H, Elble R: Treatment of patients with essential tremor. Lancet Neurol 2011;10:148-161.
-
Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T: The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 2012;27:1789-1796.
-
Vasques X, Cif L, Gonzalez V, Nicholson C, Coubes P: Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation. Mov Disord 2009;24:846-853.
-
Trottenberg T, Volkmann J, Deuschl G, Kühn AA, Schneider GH, Müller J, Alesch F, Kupsch A: Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 2005;64:344-346.
-
Martino D, Mink J: Tic disorders. Continuum (Minneap Minn) 2013;19:1287-1311.
-
Jankovic J, Gelineau-Kattner R, Davidson A: Tourette's syndrome in adults. Mov Disord 2010;25:2171-2175.
-
Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C, King RA, Sandor P, McMahon WM, Lyon GJ, Cath DC, Kurlan R, Robertson MM, Osiecki L, Scharf JM, Mathews CA: Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in tourette syndrome. JAMA Psychiatry 2015;72:325-333.
-
Marras C, Andrews D, Sime E, Lang AE: Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001;56:605-610.
Article / Publication Details
Published online: January 12, 2018
Cover Date: 2018
Number of Print Pages: 16
Number of Figures: 1
Number of Tables: 2
ISBN: 978-3-318-06201-4 (Print)
eISBN: 978-3-318-06202-1 (Online)
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission